BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Samant H, Manatsathit W, Dies D, Shokouh-Amiri H, Zibari G, Boktor M, Alexander JS. Cholestatic liver diseases: An era of emerging therapies. World J Clin Cases 2019; 7(13): 1571-1581 [PMID: 31367616 DOI: 10.12998/wjcc.v7.i13.1571]
URL: https://www.wjgnet.com/1948-5182/full/v7/i13/1571.htm
Number Citing Articles
1
Dahyeon Lee, Jeong Seop Park, Doyoung Kim, Hyun Sook Hong. Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and InflammationAntioxidants 2022; 11(5): 920 doi: 10.3390/antiox11050920
2
Touraj Ehtezazi, Khalid Rahman, Rhys Davies, Andrew G. Leach. The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s DiseaseJournal of Alzheimer's Disease Reports 2023; 7(1): 173 doi: 10.3233/ADR-220071
3
Daniela Goyes, Christopher J. Danford, Hirsh D. Trivedi, Alan Bonder. Nutrition in Cholestatic Liver DiseaseCurrent Hepatology Reports 2020; 19(1): 1 doi: 10.1007/s11901-020-00511-3
4
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno, Clarissa Berardo. Changes in Glutathione Content in Liver Diseases: An UpdateAntioxidants 2021; 10(3): 364 doi: 10.3390/antiox10030364
5
Halima Sultana, Michio Komai, Hitoshi Shirakawa. The Role of Vitamin K in Cholestatic Liver DiseaseNutrients 2021; 13(8): 2515 doi: 10.3390/nu13082515
6
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A reviewHealth Sciences Review 2022; 5: 100065 doi: 10.1016/j.hsr.2022.100065
7
Suzan M. M. Moursi, Eman El Bahaie, Amira Mohamed Abdelhamid, Sherein F. El-sayed. The Role of Apelin and Protamine Sulfate in Bile Duct Ligation-Induced Liver Fibrosis in RatsPharmaceutical Chemistry Journal 2023; 57(9): 1339 doi: 10.1007/s11094-023-02995-x
8
Dandan Song, Pei Zhu, Yankai Dong, Mengchao Wang, Anna Zhao, Hongdong Xia, Yunting Chen, Qingguang Zhou, Lun Xiang, Junyi Zhang, Guangming Luo, Yangjing Luo. Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomicsFrontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1088750
9
Naser-Aldin Lashgari, Danial Khayatan, Nazanin Momeni Roudsari, Saeideh Momtaz, Ahmad Reza Dehpour, Amir Hossein Abdolghaffari. Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathwayNaunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1433 doi: 10.1007/s00210-023-02684-2
10
Shiman Luo, Meilan Huang, Xiaohua Lu, Mingming Zhang, Huiling Xiong, Xiyue Tan, Xinyu Deng, Wenwen Zhang, Xiao Ma, Jinhao Zeng, Thomas Efferth. Optimized therapeutic potential of Yinchenhao decoction for cholestatic hepatitis by combined network meta-analysis and network pharmacologyPhytomedicine 2024; 129: 155573 doi: 10.1016/j.phymed.2024.155573
11
Andres Jose Gómez Aldana, Mónica Tapias, Adán Jose Lúquez Mindiola. Colestasis en el adulto: enfoque diagnóstico y terapéutico. Revisión de temaRevista Colombiana de Gastroenterología 2020; 35(1): 76 doi: 10.22516/25007440.375
12
Anca D. Petrescu, Sharon DeMorrow. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver InjuryCells 2021; 10(8): 1846 doi: 10.3390/cells10081846
13
Huan Lan, Ying Zhang, Minqi Fan, Bingxin Wu, Caiyan Wang. Pregnane X receptor as a therapeutic target for cholestatic liver injuryDrug Metabolism Reviews 2023; 55(4): 371 doi: 10.1080/03602532.2023.2248680
14
Shelly C. Lu. Dysregulation of glutathione synthesis in liver diseaseLiver Research 2020; 4(2): 64 doi: 10.1016/j.livres.2020.05.003
15
Guodong Li, Yanjiao Xu, Qianyan Gao, Sheng Guo, Yue Zu, Ximin Wang, Congyi Wang, Chengliang Zhang, Dong Liu. Ginsenosides Restore Lipid and Redox Homeostasis in Mice with Intrahepatic Cholestasis through SIRT1/AMPK PathwaysNutrients 2022; 14(19): 3938 doi: 10.3390/nu14193938